PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Hypertriglyceridemia 7,877 Disease Disease Hyperlipoproteinemia 2,954 265 0.05 -0.94 0.09 0.75
DC-CK1 22 Target Target CXCL3 145 1 0.02 -0.97 0.05 0.75
Acute Coronary Syndromes 9,133 Disease Target Eptifibatide 772 200 0.08 -0.85 0.26 0.75
Skin Disease 6,955 Disease Disease Psoriasis 26,882 1,207 0.09 -0.89 0.17 0.76
Angiotensin Converting Enzyme 31,674 Target Target Angiotensin-Converting Enzyme 2 665 665 0.14 -0.04 1.00 0.76
Brain Injury 34,874 Disease Disease Coma 24,208 2,350 0.08 -0.92 0.10 0.76
ACTG1 41 Target Target CALR 117 1 0.01 -0.98 0.02 0.76
Acitretin (Soriatane)- FDA 13 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 1 0.02 -0.96 0.08 0.76
Atropine (Atropine)- FDA 13 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 1 0.02 -0.96 0.08 0.76
ACVR1B 23 Target Target BMPR1A 279 2 0.02 -0.95 0.09 0.76
Back Pain 30,003 Disease Disease Pain 409,851 30,003 0.27 -0.01 1.00 0.76
Chronic Pain 21,087 Disease Disease Fibromyalgia 6,837 960 0.08 -0.91 0.14 0.76
AMY2B 21 Target Target Pancreatic Alpha-Amylase 423 3 0.03 -0.92 0.14 0.76
Thrombocytopenia 35,805 Disease Disease Anemia 81,663 6,363 0.12 -0.87 0.18 0.76
Acne 11,364 Disease Disease SAPHO Syndrome 378 205 0.10 -0.67 0.54 0.76
Doxorubicin Hydrochloride 581 Drug Drug Doxorubicin 28,033 581 0.14 -0.04 1.00 0.76
Tubulin Beta-1 Chain 3 Target Target Inosine-5'-Monophosphate Dehydrogenase 261 1 0.04 -0.81 0.33 0.76
Antisocial Personality Disorder 1,468 Disease Disease Narcissistic Personality Disorder 232 23 0.04 -0.94 0.10 0.76
CCL2 3,560 Target Target CCL1 220 55 0.06 -0.86 0.25 0.76
Atropen (Atropine)- FDA 11 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 1 0.02 -0.95 0.09 0.76
Atropine (Atropen)- FDA 11 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 1 0.02 -0.95 0.09 0.76
Phobias 1,578 Disease Disease Panic Disorder 7,455 219 0.06 -0.91 0.14 0.76
CXCL16 341 Target Target CXCL10 2,386 43 0.05 -0.93 0.13 0.76
Parkinsonism 13,164 Disease Disease Dyskinesia 9,738 692 0.06 -0.94 0.07 0.76
CXCL11 526 Target Target CXCL4/PF4 9 3 0.04 -0.81 0.33 0.76
Androgen Receptor 12,918 Target Disease Prostate Cancer 71,064 4,112 0.14 -0.80 0.32 0.76
Ativan (Lorazepam)- FDA 10 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 1 0.02 -0.95 0.10 0.76
Aldosterone Receptor 528 Target Drug Drospirenone 514 11 0.02 -0.98 0.02 0.76
CCL19 658 Target Target CCL18 256 11 0.03 -0.97 0.04 0.76
ELC 355 Target Target CCL21 808 15 0.03 -0.97 0.04 0.76
Mu Opioid Receptor 4,576 Target Target Opioid Receptor Mu 71 51 0.09 -0.53 0.72 0.76
Conjunctivitis 8,825 Disease Disease Keratitis 10,599 548 0.06 -0.94 0.06 0.76
EPHA2 532 Target Target EPHB3 118 7 0.03 -0.96 0.06 0.76
Doxazosin 1,316 Drug Disease Benign Prostatic Hyperplasia 10,026 285 0.08 -0.87 0.22 0.76
BLK 255 Target Target CD72 198 4 0.02 -0.98 0.02 0.76
Anemia 81,663 Disease Disease Sickle Cell 17,551 5,333 0.14 -0.81 0.30 0.76
Gallstones 8,280 Disease Disease Gallbladder Disease 1,424 245 0.07 -0.90 0.17 0.76
Metastatic Breast Cancer 9,288 Disease Disease Breast Cancer 173,695 9,288 0.23 -0.01 1.00 0.76
CEA 17,022 Target Target CA 15-3 898 437 0.11 -0.71 0.49 0.76
CCL5 2,002 Target Target CXCL10/IP-10 114 27 0.06 -0.87 0.24 0.76
Eotaxin 2,457 Target Target Eotaxin-2/CCL24 19 19 0.09 -0.22 1.00 0.76
Hepatitis B 57,815 Disease Disease Liver Disease 49,817 5,307 0.10 -0.90 0.11 0.76
Exodus-2 27 Target Target CCL21 808 7 0.05 -0.86 0.26 0.76
Chronic Pain 21,087 Disease Disease Acute Pain 4,876 934 0.09 -0.88 0.19 0.76
CCL3 1,427 Target Target CXCL3 145 21 0.05 -0.92 0.14 0.76
CXCL16 341 Target Target CCL18 256 6 0.02 -0.98 0.02 0.76
Parkinsons Disease 124 Disease Target DJ-1/PARK7 21 1 0.02 -0.97 0.05 0.76
CCL5 2,002 Target Target CCL1 220 34 0.05 -0.91 0.15 0.76
CCL19 658 Target Target CCL7 274 12 0.03 -0.97 0.04 0.76
Antisocial Personality Disorder 1,468 Disease Disease Personality Disorders 6,349 197 0.06 -0.92 0.13 0.76
Hearing Loss 30,622 Disease Disease Vertigo 10,084 1,734 0.10 -0.88 0.17 0.76
CCL19 658 Target Target CXCL16 341 13 0.03 -0.97 0.04 0.76
Endometriosis 16,342 Disease Disease Dysmenorrhea 3,263 654 0.09 -0.88 0.20 0.76
Activase (Alteplase)- FDA 112 Drug Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.02 -0.98 0.04 0.76
Alteplase (Activase)- FDA 112 Drug Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.02 -0.98 0.04 0.76
Acetic Acid (Acetic Acid)- FDA 168 Drug Drug Amaryl (Glimepiride)- FDA 7 1 0.03 -0.92 0.14 0.76
AMY2B 21 Target Target APOA2 118 1 0.02 -0.97 0.05 0.76
Adenosine A3 Receptor 164 Target Target Adenosine A1 Receptor 1,432 23 0.05 -0.92 0.14 0.76
CCL3 1,427 Target Target CXCL11 526 33 0.04 -0.96 0.06 0.76
Doxycycline Hyclate 145 Drug Drug Doxycycline 9,324 145 0.12 -0.08 1.00 0.76
4-1BB Receptor 20 Target Target CD137 474 4 0.04 -0.89 0.20 0.76
Glutathione Transferase Omega-1 14 Target Target Glutathione Peroxidase 3 132 1 0.02 -0.96 0.07 0.76
CA125 Antigen 78 Target Target BD2 76 1 0.01 -0.99 0.01 0.76
Allergies 10,264 Disease Disease Allergic Rhinitis 12,280 721 0.06 -0.94 0.07 0.76
CCL19 658 Target Target CCL3 1,427 36 0.04 -0.96 0.05 0.76
CCL18 256 Target Target CCL3 1,427 27 0.04 -0.94 0.11 0.76
Glutathione Peroxidase 3 132 Target Target Glutathione Peroxidase 6 13 1 0.02 -0.96 0.08 0.76
Phobias 1,578 Disease Disease Separation Anxiety 1,096 47 0.04 -0.96 0.04 0.76
CXCL16 341 Target Target CCL8 197 6 0.02 -0.98 0.03 0.76
Hepatitis 163,842 Disease Disease Liver Disease 49,817 15,950 0.18 -0.78 0.32 0.77
CCL19 658 Target Target CCL5 2,002 52 0.05 -0.95 0.08 0.77
AMBP 160 Target Target A1M 59 2 0.02 -0.98 0.03 0.77
Allergies 10,264 Disease Disease Eczema 12,327 748 0.07 -0.93 0.07 0.77
CD22 1,591 Target Target CD72 198 29 0.05 -0.92 0.15 0.77
Snoring 4,669 Disease Disease Sleep Disorders 6,847 331 0.06 -0.94 0.07 0.77
APOA2 118 Target Target APOC1 126 2 0.02 -0.98 0.02 0.77
CXCL16 341 Target Target CCL7 274 7 0.02 -0.98 0.03 0.77
FABP1 90 Target Target Carbonic Anhydrase 3 36 1 0.02 -0.98 0.03 0.77
Glutaredoxin-1 142 Target Target Glutathione S-Transferase Mu 2 8 1 0.03 -0.93 0.12 0.77
Aurora Kinase A 196 Target Target AURKC 26 2 0.03 -0.96 0.08 0.77
Nausea 42,627 Disease Disease Diarrhea 51,986 4,978 0.11 -0.89 0.12 0.77
Aurora Kinase A 196 Target Target Aurora A kinase 318 6 0.02 -0.98 0.03 0.77
Social Anxiety 3,287 Disease Disease Panic Disorder 7,455 330 0.07 -0.93 0.10 0.77
CCL7 274 Target Target CXCL11 526 11 0.03 -0.97 0.04 0.77
A1M 59 Target Target B2M 677 9 0.05 -0.91 0.15 0.77
EPHA4 357 Target Target EPHB4 329 8 0.02 -0.98 0.02 0.77
Accolate (Zafirlukast)- FDA 4 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 1 0.04 -0.86 0.25 0.77
Atazanavir Sulfate (Reyataz)- FDA 40 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 2 0.02 -0.97 0.05 0.77
CXCL16 341 Target Target CXCL3 145 6 0.03 -0.97 0.04 0.77
Abilify (Aripiprazole)- FDA 71 Drug Drug Acetaminophen (Tylenol)- FDA 69 1 0.01 -0.99 0.01 0.77
Acetaminophen (Tylenol)- FDA 69 Drug Drug Aripiprazole (Abilify)- FDA 71 1 0.01 -0.99 0.01 0.77
CCL18 256 Target Target CXCL11 526 11 0.03 -0.97 0.04 0.77
CCL7 274 Target Target CXCL10 2,386 51 0.06 -0.89 0.19 0.77
Fracture 111,575 Disease Disease Osteoporosis 46,215 11,132 0.16 -0.83 0.24 0.77
Endometriosis 16,342 Disease Disease Infertility 35,448 2,590 0.11 -0.88 0.16 0.77
CCL7 274 Target Target CXCL7 76 4 0.03 -0.97 0.05 0.77
Eotaxin 2,457 Target Target Eotaxin-3/CCL26 26 26 0.10 -0.19 1.00 0.77
CXCL16 341 Target Target CXCL7 76 5 0.03 -0.96 0.07 0.77
CCL18 256 Target Target CCL8 197 5 0.02 -0.98 0.03 0.77
Diabetic Nephropathy 12,496 Disease Disease Proteinuria 28,803 1,957 0.10 -0.89 0.16 0.77